Literature DB >> 10048904

Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.

R B Hays1, S M Kegeles.   

Abstract

Given their high seroincidence, young gay men will be targeted for recruitment into HIV vaccine trials but many challenges stand in the way of enlisting their cooperation. This study examined factors associated with young gay men's willingness to participate in vaccine trials and identified reasons for agreeing or not agreeing to participate. The data come from the Young Men's Survey, a cohort of western U.S. young gay men aged 18 to 29 years, surveyed using mail-back questionnaires. Participants who reported being HIV-negative or who had not been tested for HIV (n = 390) were asked to rate their desire to be given an HIV vaccine and their degree of willingness to participate in a vaccine trial. They also responded to open-ended questions regarding their reasons for participating or not participating. Of these respondents, 91% wanted to be given an HIV vaccine, yet many had serious reservations about participating in a vaccine trial. Men who had engaged in HIV risk behavior reported greater willingness to participate. The most common reasons for wanting to participate were desires to contribute to ending the AIDS epidemic and desire to help others; however, fears for one's own health and safety made many reluctant to participate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048904     DOI: 10.1097/00042560-199902010-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  16 in total

Review 1.  Building and testing an effective HIV vaccine.

Authors:  J Kahn
Journal:  West J Med       Date:  1999 Nov-Dec

2.  Using an integrated approach to understand vaccination behavior among young men who have sex with men: stages of change, the health belief model, and self-efficacy.

Authors:  Scott D Rhodes; Kenneth C Hergenrather
Journal:  J Community Health       Date:  2003-10

3.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

4.  Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.

Authors:  Chelsea D Voytek; Kevin T Jones; David S Metzger
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

Review 5.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 6.  Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.

Authors:  Shayesta Dhalla; Gary Poole
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.

Authors:  Paula M Frew; Mark J Mulligan; Su-I Hou; Kayshin Chan; Carlos del Rio
Journal:  Open Access J Clin Trials       Date:  2010-09-01

8.  Typologies of Altruistic and Financial Motivations for Research Participation.

Authors:  Lisa J Chin; Jacqueline A Berenson; Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2016-10       Impact factor: 1.742

9.  In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

Authors:  Paula M Frew; Wendy Macias; Kayshin Chan; Ashley C Harding
Journal:  J Health Mass Commun       Date:  2009

10.  Engaging members of African American and Latino communities in preventive HIV vaccine trials.

Authors:  Magdalena E Sobieszczyk; Guozhen Xu; Krista Goodman; Debbie Lucy; Beryl A Koblin
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.